tirzepatide weight loss study Semaglutide vs Tirzepatide: Which GLP-1 Wins for Loss? Tirzepatide causes more weight loss

The rate of GLP-1 receptor agonist use rose more than threefold during the study period, from 8.6% in 2018 to 26.8% in 2023, the researchers found

Benefits of Semaglutide Semaglutide is a bioidentical synthetic hormone peptide that contains 29 amino acids and may be used in conjunction with bioidentical hormone replacement therapy (BHRT), weight loss programs, and erectile dysfunction treatment

Those with a history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or certain pancreatitis concerns should discuss risks with a provider

At first, they started looking for different hormonal targets, one of which was glucagon, a hormone associated with raising blood glucose